SMTL ID : 8w0y.2 (1 other biounit)

Crystal structure of broadly neutralizing antibody hcab17 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.31 Å
Oligo State
hetero-1-1-1-mer
Ligands
3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Ogega, C.O. et al., Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance. Immunity (2024)
Release Date
2024-03-27
Peptides
Envelope glycoprotein E2: A
hcab17 Fab Heavy Chain: B
hcab17 Fab Light Chain: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
C
B
H
C
L

Envelope glycoprotein E2

hcab17 Fab Heavy Chain

hcab17 Fab Light Chain

Related Entries With Identical Sequence

6meh.1 | 7rfb.1 | 7rfb.2 | 7rfc.1 | 7rfc.2 | 8w0v.1 | 8w0w.1 | 8w0x.1 | 8w0y.1